LG G PAD X II 10.1, Руководство пользователя

Страница: 110 / 120

For Your Safety 109
actions, the FDA has urged the tablet industry to take a number of steps,
including the following:
Ţ
Support needed research into possible biological effects of RF of the
type emitted by tablets;
Ţ
Design tablets in a way that minimizes any RF exposure to the user
that is not necessary for device function; and
Ţ
Cooperate in providing users of tablets with the best possible
information on possible effects of tablet use on human health.
The FDA belongs to an interagency working group of the federal agencies
that have responsibility for different aspects of RF safety to ensure
coordinated efforts at the federal level. The following agencies belong to
this working group:
Ţ
National Institute for Occupational Safety and Health
Ţ
Environmental Protection Agency
Ţ
Occupational Safety and Health Administration
Ţ
National Telecommunications and Information Administration
The National Institutes of Health participates in some interagency working
group activities, as well.
The FDA shares regulatory responsibilities for tablets with the Federal
Communications Commission (FCC). All tablets that are sold in the United
States must comply with FCC safety guidelines that limit RF exposure.
The FCC relies on the FDA and other health agencies for safety questions
about tablets.
The FCC also regulates the base stations that the tablet networks rely
upon. While these base stations operate at higher power than do the
tablets themselves, the RF exposures that people get from these base
stations are typically thousands of times lower than those they can
get from tablets. Base stations are thus not the subject of the safety
questions discussed in this document.
3. What kinds of devices are the subject of this update?
The term “wireless device” refers here to handheld wireless devices with
built-in antennas, often called “cell”, “mobile”, or “PCS” devices. These types
of wireless devices can expose the user to measurable Radio Frequency